$7 million grant renewal supports cancer drug discovery research based on compounds found in nature

COLUMBUS, Ohio -The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) and the Ohio State College of Pharmacy have been awarded a five-year, $7 million competitive Program Project Grant (PPG) grant renewal from the National Cancer Institute (NCI). This multidisciplinary project grant…

Details

Research could change how blood pressure is managed in spinal cord injury patients

New research from the International Collaboration on Repair Discoveries (ICORD) challenges the current standard for managing blood pressure in people with spinal cord injury (SCI). The findings, published today in Nature Communications, could lead to a change in the way newly injured patients have their blood pressure managed, potentially improving their chances of retaining more…

Details

Start-up awarded grant to develop contrast agent for early detection of liver disease

ATLANTA–Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver…

Details

Conquering CHD, Children’s Hospital Colorado encourage others to provide cardiac outcomes

Aurora, Colo. (Oct. 15, 2020) – Congenital Heart Disease (CHD) is the most common birth defect in the United States, occurring in approximately one in every 100 babies. However, hospital data regarding short- and long-term outcomes for patients has been limited and oftentimes difficult to access and/or interpret. “Children’s Hospital Colorado has long been committed…

Details

New bioprosthetic valve for TAVR fails to demonstrate non-inferiority

NEW YORK – October 15, 2020 – In a randomized clinical trial, SCOPE II, a new self-expanding bioprosthetic valve used in transcatheter aortic valve replacement (TAVR) failed to demonstrate non-inferiority compared to an existing self-expanding valve. Findings were reported today at TCT Connect, the 32nd annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT…

Details